Crinetics Pharmaceuticals (CRNX) Return on Capital Employed Growth (1y) (2019 - 2026)
Crinetics Pharmaceuticals (CRNX) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 2,400.00 |
| 10 | Crinetics Pharmaceuticals | 8.72 Bn | 7.43 Bn | 10.53 Mn | -1,766.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,766.00 |
| Dec 31, 2025 | -1,794.00 |
| Sep 30, 2025 | -614.00 |
| Jun 30, 2025 | -286.00 |
| Mar 31, 2025 | 477.00 |
| Dec 31, 2024 | 736.00 |
| Sep 30, 2024 | 1,386.00 |
| Jun 30, 2024 | 4,004.00 |
| Mar 31, 2024 | 2,647.00 |
| Dec 31, 2023 | 1,182.00 |
| Sep 30, 2023 | -868.00 |
| Jun 30, 2023 | -3,226.00 |
| Mar 31, 2023 | -2,249.00 |
| Dec 31, 2022 | -849.00 |
| Sep 30, 2022 | 921.00 |
| Jun 30, 2022 | 1,147.00 |
| Mar 31, 2022 | 1,222.00 |
| Dec 31, 2021 | 55.00 |
| Sep 30, 2021 | -1,492.00 |
| Jun 30, 2021 | -949.00 |